Epithelial-Mesenchymal Transition (EMT), interferon gamma response, IL2/STAT5 signaling and some other pathways are activated in the high risk group, which manifest immune suppression (36), drug resistance (37), tumor evasion (38). This evidence concerns the gene IL2 and neoplasm.